Stay updated on L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial
Sign up to get notified when there's something new on the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page.

Latest updates to the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the expected study record details, indicating an access restriction rather than a change to the study information.SummaryDifference15%

- Check21 days agoChange DetectedThe page shows a new site version tag (v3.7.0) replacing the previous v3.6.6, indicating a release update to the interface without altering the study details.SummaryDifference0.1%

- Check35 days agoChange DetectedThe Revision text on the page updated from v3.6.5 to v3.6.6, reflecting a new site build.SummaryDifference0.1%

- Check57 days agoChange DetectedThe site's revision number was updated from v3.6.4 to v3.6.5, indicating a platform update. The study details and layout remain unchanged.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page's revision tag in the footer changed from v3.6.3 to v3.6.4, signaling a minor update to the ClinicalTrials.gov study page. This update represents a background page revision and does not modify study details, eligibility, or results.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page revision tag changed from v3.6.0 to v3.6.3, indicating an updated version of the page template was deployed. This change does not alter study details, interfaces, or user actions on the page.SummaryDifference0.1%

Stay in the know with updates to L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the L-PPDS Dose Evaluation in Ocular Hypertension Clinical Trial page.